`
`In Re:
`
`U.S. Patent of Marks er a3.
`
`Proceeding N0.:
`
`IPR201?-01063
`
`Patent No.:
`
`9,006,224
`
`Application N0.:
`
`l2r’094,1'i"3
`
`For:
`
`NEUROENDOCRINE TUMOR TREATMENT
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PAR TES REVIEW
`
`Patent Owner Novartis AG (“Novartis”) hereby appoints Nicholas N. Kallas (Reg.
`
`No. 31,530) and Laura K. Fishwick (Reg. No. 69,907) as its attorneys to prosecute the
`
`aforementioned proceeding and to transact all business in the United Patent and Trademark
`
`Office connected therewith.
`
`Please address all correspondence as follows:
`
`Nicholas N. Kallas
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`nkallas@fchs.co1n
`
`'
`
`Datep: March -:2 2017
`/4" 7"
`
`201 7
`Dated: M rch
`’
`-
`I
`.
`,-’-
`’
`/ " 1,~.,;:.;, 5,;
`
`Gregory Hou
`ton
`Gre ory Ferraro
`Novartis Pharmaceuticals Corporation
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`One Health Plaza
`
`East Hanover, NJ 07936-1080
`
`East Hanover, NJ 07936-1080
`
`Witnessed by:
`
`” we
`
`Signature
`
`Witnessed by:
`
`x—~
`._/got
`
`Signature
`
`\
`/1.-
`
`M 1 Cl/Lg: 11;:
`Printed name
`
`H1. 5
`
`M : ch 1 :1,
`Printed name
`
`11 [Q
`
`FCHS___WS l329330Sv I don:
`
`
`
`{l) NOVARTIS
`
`Power of Attorney
`(To Novartis IP colleagues based in AT, CN, DE, IN, SI, SG, US)
`
`By this Power of Attorney, effective 01 January 2017, Novartis AG, a company
`incorporated under the laws of Switzerland and having its principal place of business at
`Lichtstrasse 35, 4056 Basel, Switzerland ("the Company"), hereby grants to the Novartis
`Group Companies listed below ("the Corporate Signatories"):
`
`a) the revocable authority to sign documents on behalf of the Company in
`connection with filing, prosecution, maintenance, and administration of any
`intellectual property right
`for copyright, design, domain name, patent,
`supplementary protection certificate (SPC) and trademark registration or any
`application therefore standing in the name of the Company ("IP");
`
`b) the revocable authority to sign documents on behalf of the Company in
`connection with litigation relating to defense of IP before a governmental
`authority; and
`
`c) the revocable authority to sign Confirmatory Assignments on behalf of the
`Company. "Confirmatory Assignments" are agreements between the Company
`and a third party or a Novartis Group entity that do not create new rights or
`obligations for the Company, such rights having been created by an underlying
`agreement (e.g. acquisition/divestment agreement, research funding/collaboration
`agreement, and the like) and whereby the Confirmatory Assignment merely
`executes the transfer of IP as agreed in such underlying agreement;
`
`and for no other purposes.
`
`This Power of Attorney excludes the power to conclude contracts, other than
`Confirmatory Assignments, or to enter into settlements on behalf of the Company.
`The
`terms
`"contracts"
`and
`"settlements"
`include
`license
`agreements,
`acquisition/divestment agreements, assignments, prior right agreements and/or letters of
`consent.
`
`This Power of Attorney includes the power to appoint external agents within the scope of
`this Power of Attorney.
`
`To be legally binding upon the Company, all relevant documents require the signature of
`two employees of one or more of the Corporate Signatories as set out below ("Personal
`Signatories") who are authorized to sign for their respective Corporate Signatory, except
`where a single Personal Signatory is permitted according to the Novartis internal
`"Intellectual Property Signature Guidelines".
`
`
`
`Corporate Signatories
`
`Personal Signatories
`
`Alcon Research, Ltd.
`
`Barbara McKenzie
`Barry L. Copeland
`Candy Sanders
`Christianne K. Garrow
`Christine Bohmann
`Darien L. Reddick
`Deborah Weinschenk
`Deena Nutt
`Denise C. Vivar
`Glenda Wolfe
`Janis M. Mendolia
`Jason Finch
`Jian Zhou
`Keiko Ichiye
`Kelly Bryant
`Kenneth D. Bassinger
`Martha J. Martin
`Michael Rein
`Patrick M. Ryan
`Robert Ambrose
`Russell E. Henrichs
`Matthew A. Hayenga
`Shelley Rose-Johnson
`Sheng-Hsin Hu
`Stephanie J. Boyle
`Steven Brannon Latimer
`Tamika Adams
`Tracy Humphreys
`Vanessa Backman
`Yolanda I. Sanchez
`
`Andrea Felbermeir
`Britta Chamberlain
`David Lossignol
`Manuela Hillewaert
`Meike Urban
`Susanne Groschel
`Timo Getting
`Rob Gorman
`Robin Ellis
`Sebastian Trott
`
`Page 2 of 5
`
`Sandoz International GmbH
`
`
`
`Corporate Signatories
`
`Personal Signatories
`
`Hexal AG
`
`LEK Pharmaceuticals d.d.
`
`Sandoz GmbH
`
`Novartis Institutes for BioMedical Research, Inc.
`
`Harald Kluschanzoff
`Monika Le-Good
`
`Barbara Kunic-Tesovic
`Urska Gros
`
`Andreas Blecha
`Simone Leitmann
`
`Adam Poulin-Kerstein
`David Carpenter
`Elissa Marie Nash
`Grace Law
`Hong-Van M. Le
`Jean Silveri
`John B. Alexander
`John Prince
`Jonathan Wood
`Joshua Roth
`Kathleen Drury
`Laura Madden
`Laurie Butler Lawrence
`Mei Benni
`Michael G. Smith
`Qian Zhang [5-kil]
`Rona Nardone
`Safiya Watson
`Shawn Britt
`Simonne Corriveau
`Scott Brown
`Scott Loftus-Reid
`Sophie Binet Cross
`Stephanie Geis
`Stephen Wolfolds
`Susan Dillon
`Xiaoguang Gao
`
`Page 3 of 5
`
`
`
`Corporate Signatories
`
`Personal Signatories
`
`Novartis Institute for Functional Genomics, Inc.
`
`Ciba Vision Vertriebs GmbH
`
`Chihang (Amy) Smith
`Daniel E. Raymond
`EmilyT. Wu
`Julie McCarthy
`Kun Wang
`Susan Sesnovich
`
`Frank Kaul
`Frank Hauerken
`Jan-Thore Fohrenbach
`
`Novartis Institute for Tropical Diseases Pte. Ltd.
`
`Y ounbeen Kim
`
`Beijing Novartis Pharma Co. Ltd.
`[ ~ t:JjH~ $!ffU t;!J ~ ~~ 0 1§J]
`
`Novartis Services Incorporated
`
`Novartis Healthcare Private Limited
`
`Fan (Kent) Yang [i%$JL]
`Lu Dai [txit]
`John Ti Li [*:tmt~]
`Juan (Jane) Ye [llt~foi]
`Zheng (Aileen) Wei [~<ijf]
`Xiaoning (Remy) Wang (£!J\'T]
`
`Corey Salsberg
`Cynthia L. Lopez
`Frank Smith
`Jennifer Phillips
`Juerg Baenziger
`
`Atul Bade
`Ashish Jogi
`
`Page 4 of 5
`
`\
`
`I
`
`
`
`Corporate Signatories
`
`Personal Signatories
`
`Novartis Pharmaceuticals Corporation
`
`Andrea Jacquin
`Andrew Holmes
`Annette Cromer
`Bernadeta Adach
`Christine McCormack
`Cindy Klepacky
`Daniel Woods
`David Cheung
`David Kurlandsky
`Diane Leone
`Gregory Ferraro
`Gregory Houghton
`Jason J. Derry
`Jennifer Chapman
`Jim Lynch
`Kamalam Suppiah
`Kelly Stritenberger
`Lauren Bosco
`Leslie Fischer
`Linda Adams
`Lydia McNally
`Maria Stachura
`Marie Collazo
`Mark E. Flanigan
`Matthew Mulkeen
`Mehdi Ganjeizadeh
`Michael Mazza
`Michelle Han
`Peter Waibel
`Sandra Rueck
`Scott A. Chapple
`Sherri Rose
`Sudipta Rao
`Svetlana Korzhin
`
`This Power-of-Attorney is valid until 31st December 2017 and supersedes as of its
`effective date all previous versions of Powers of Attorney relating to the subject matter
`herein.
`
`Basel, 21 December 2016,
`NOVARTISAG
`
`vJ n __
`----------~---~--------------------------
`F'1"'" e...
`N : <-ho\0-.f
`Authorized Signatory
`
`\ A-rJ \-liS <:A) q_(
`Authorized Signatory
`
`Page 5 of 5
`
`
`
`ATTESTATION
`
`I, the undersigned Civil Law Notary in Basel, Switzerland, Dr. Thomas Gelzer, certify
`herewith that the signatures attached heretofore are the genuine signatures of Mr. Ian
`Hiscock, British citizen, residing in Gempen, Switzerland; and of Mr. Nicholas Finnie,
`British citizen, residing in Basel, Switzerland; both acting for Novartis AG, in Basel,
`Switzerland, both as authorized signatories, both with joint signature.
`
`~ authenticity of the signatures was established by means of comparison.
`
`~ E t!! Switzerland, this 27th (twenty-seventh) day of December 2016 (two thousand and
`six ~ en ~
`
`-I
`
`I~
`L
`D~. Th. Gelzer
`
`No tar
`
`